Scientific Research
A deeper look at the research, mechanisms, and findings behind each peptide in our catalog. All compounds are for qualified research use only.
Every compound is synthesized using solid-phase peptide synthesis (SPPS) to ensure sequence accuracy, structural integrity, and batch-to-batch consistency.
Independent HPLC, mass spectrometry, and amino acid analysis conducted on every production batch to confirm identity and purity ≥99.0%.
Manufactured in US-based facilities operating under cGMP-aligned quality standards, with full chain-of-custody documentation available on request.
Body Protection Compound 157
BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, derived from a protective protein found naturally in gastric juice. It has been the subject of extensive preclinical research for its regenerative and cytoprotective properties.
Research suggests BPC-157 modulates the nitric oxide (NO) system and upregulates growth hormone receptors, promoting angiogenesis and accelerating wound healing. Studies have demonstrated interactions with the dopaminergic, serotonergic, and GABAergic pathways, as well as activation of the FAK-paxillin pathway to facilitate cell migration.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Synthetic Thymosin Beta-4 Fragment
TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring 43 amino acid peptide ubiquitously expressed in virtually all human and animal cells. It has been extensively studied for its role in tissue repair and cellular regeneration.
Thymosin Beta-4 binds G-actin monomers with high affinity, sequestering them and regulating actin polymerization. This action is central to cell motility, wound healing, and angiogenesis. TB-500 specifically promotes the upregulation of cell-building proteins such as actin and myosin, enhancing the migration of endothelial cells and keratinocytes to sites of injury.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
GLP Receptor Targeting Peptide
GLP-3 RT represents a next-generation approach to GLP receptor modulation. It is studied for its influence on incretin signaling, metabolic homeostasis, and appetite regulation — areas of significant pharmaceutical interest for the management of metabolic disorders.
GLP receptor agonists mimic the action of endogenous incretin hormones, stimulating insulin secretion in a glucose-dependent manner while suppressing glucagon release. Research suggests GLP-3 RT exerts effects on central appetite regulation via hypothalamic pathways, influencing satiety signaling and energy balance.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Selective Growth Hormone Secretagogue
Ipamorelin is a pentapeptide and selective growth hormone secretagogue that binds the ghrelin receptor (GHS-R1a). It is unique among GH-releasing peptides for its high selectivity — stimulating GH release without significantly affecting cortisol, prolactin, or ACTH levels.
Ipamorelin acts on the pituitary gland and hypothalamus to stimulate the pulsatile release of endogenous growth hormone. Unlike other GH secretagogues, it does not activate the hypothalamic–pituitary–adrenal (HPA) axis, making it a cleaner secretagogue profile. Its selectivity is attributed to its specific binding affinity for the GHSR-1a receptor.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Synthetic GHRH Analog
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of the full 44 amino acid sequence of human GHRH with a trans-3-hexenoic acid group attached for enhanced stability. Its pharmacological profile has been studied in the context of metabolic and body composition research.
Tesamorelin binds to GHRH receptors on pituitary somatotrophs, stimulating the synthesis and pulsatile secretion of endogenous growth hormone. This downstream GH release elevates IGF-1 levels, which in turn mediates lipolysis in visceral adipose tissue through hormone-sensitive lipase activation.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Nicotinamide Adenine Dinucleotide
NAD+ is a critical coenzyme found in all living cells, serving as a central mediator of energy metabolism and a key substrate for enzymes involved in DNA repair, gene expression, and cellular stress response. Its systemic levels decline significantly with age, making it a major focus of longevity research.
NAD+ functions as an electron carrier in the mitochondrial electron transport chain, accepting electrons from NADH to generate ATP via oxidative phosphorylation. Beyond energy metabolism, NAD+ is the sole substrate for sirtuin deacetylases (SIRT1–SIRT7) and PARPs, which regulate chromatin structure, DNA damage repair, and inflammatory signaling.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Mitochondria-Derived Peptide
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a novel peptide encoded within the mitochondrial genome, placing it in a unique class of mitochondria-derived peptides (MDPs). It has emerged as a significant regulator of systemic metabolic homeostasis.
MOTS-C activates the AMPK pathway, a master regulator of cellular energy sensing. Under metabolic stress, MOTS-C translocates from the mitochondria to the nucleus, where it regulates the expression of antioxidant response element (ARE)-driven genes. This action enhances insulin sensitivity and reduces lipid accumulation in skeletal muscle.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Alpha-MSH C-Terminal Tripeptide
KPV (Lysine-Proline-Valine) is a tripeptide representing the C-terminal active fragment of alpha-melanocyte stimulating hormone (α-MSH). It has been identified as a potent anti-inflammatory and immunomodulatory agent with both systemic and local effects.
KPV exerts its anti-inflammatory effects through melanocortin receptor-dependent and independent pathways. It directly inhibits pro-inflammatory transcription factors including NF-κB, reducing the production of cytokines such as IL-1β, TNF-α, and IL-6. Additionally, KPV modulates mucosal immune responses, making it of particular interest in gastrointestinal inflammation research.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.
Long R3 Insulin-like Growth Factor 1
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a recombinant analog of human IGF-1 in which the glutamic acid at position 3 is replaced by arginine and a 13 amino acid extension is added to the N-terminus. These modifications significantly enhance its potency and half-life.
IGF-1 LR3 binds to IGF-1 receptors (IGF1R) on target cells with high affinity but has substantially reduced binding to IGF-binding proteins (IGFBPs) compared to native IGF-1. This results in a longer systemic half-life and greater bioavailability at target tissues. It activates the PI3K/Akt/mTOR pathway, promoting protein synthesis, cellular proliferation, and inhibition of apoptosis.
All data pertains to preclinical or in vitro research only. Maxx Labs compounds are for research use by qualified professionals. Not intended for human therapeutic use.